Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jul 21 2021 | Understanding the Underlying Challenge in Heart Failure: Heart Muscle Contraction and Its Role in Heart Failure with Reduced Ejection Fraction (HFrEF) Patient News Heart Failure Awareness 365 Patient Resource Read More Jul 14 2021 | Heart Failure Awareness 365: Treatment Plans, Medications, and Cardiac Rehabilitation Patient News Heart Failure Awareness 365 Patient Resource Read More Jul 10 2021 | Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes Industry News Industry Read More Jul 9 2021 | HFSA Annual Scientific Meeting 2021 Schedule at a Glance Out Now HFSA News Annual Scientific Meeting Read More Jul 6 2021 | Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction Industry News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 73 Page 74 Page 75 Page 76 Current page 77 Page 78 Page 79 Page 80 Page 81 … Next page Next › Last page Last »
Jul 21 2021 | Understanding the Underlying Challenge in Heart Failure: Heart Muscle Contraction and Its Role in Heart Failure with Reduced Ejection Fraction (HFrEF) Patient News Heart Failure Awareness 365 Patient Resource Read More
Jul 14 2021 | Heart Failure Awareness 365: Treatment Plans, Medications, and Cardiac Rehabilitation Patient News Heart Failure Awareness 365 Patient Resource Read More
Jul 10 2021 | Bayer’s KERENDIA® (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes Industry News Industry Read More
Jul 9 2021 | HFSA Annual Scientific Meeting 2021 Schedule at a Glance Out Now HFSA News Annual Scientific Meeting Read More
Jul 6 2021 | Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction Industry News Industry Read More
